Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for September 2015

    ... chelation therapy with deferasirox compared to placebo in patients with myelodysplastic syndromes (low/int-1 risk) and ...

    Page last updated 08/26/2015 - 1:05pm.

  2. Clinical Trials Report for April 2014

    ... Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell ... Safety of oral Azacitidine plus best supportive care versus placebo and best supportive care in subjects with red blood cell (RBC) ...

    Page last updated 04/18/2014 - 3:36pm.

  3. Clinical Trial Basics

    ... the new study treatment, the standard treatment, or a placebo . Clinical trials may compare a new medical approach to a standard one that is already available or to a placebo that contains no active ingredients or to no intervention. Some ...

    Page last updated 01/20/2015 - 4:58pm.

  4. Clinical Trial Basics

    ... the new study treatment, the standard treatment, or a placebo . Clinical trials may compare a new medical approach to a standard one that is already available or to a placebo that contains no active ingredients or to no intervention. Some ...

    Page last updated 01/20/2015 - 4:46pm.

  5. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ... in the romiplostin group and the group treated with a placebo . In other words, with additional follow-up, there actually did not ...

    Interview last updated 02/07/2013 - 1:28pm.

  6. Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

    ... or subcutaneously x 7 days every 4 weeks Drug: Placebo (for 33A) Placebo supplied in single-use vials matching 33A ...

    Clinical Trial last updated 04/29/2016 - 12:55pm.

  7. Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

    ... or withdrawal of consent, or lack of response. Drug: Placebo Matching Placebo to Imetelstat will be administered. ...

    Clinical Trial last updated 04/20/2016 - 3:39pm.

  8. Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

    ... IM Other Name: CMV-MVA Triplex Vaccine Other: Placebo Given IM Other Names: placebo therapy PLCB sham therapy ...

    Clinical Trial last updated 04/29/2016 - 11:00am.

  9. Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

    ... Biological: CMVpp65-A*0201 peptide vaccine Given SC Other: Placebo Given SC Other Name: PLCB Other: Laboratory Biomarker ...

    Clinical Trial last updated 04/29/2016 - 2:03pm.

  10. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ... Drug: 300 mg Oral Azacitidine Maintenance therapy Drug: Placebo ...

    Clinical Trial last updated 04/29/2016 - 8:39am.